Related content
How a client avoided $109M in pharmacy costs
View the Optum Rx Drug Pipeline Insights Report for 2022.
5 questions: Optum Rx chief pharmacy officer
Michael Einodshofer addresses the risks, challenges and opportunities facing the industry.
Regulatory developments in pharmacy 2022, 2023
We discuss the Inflation Reduction Act, the drug pricing executive order and other federal and state regulations passed in 2022. We also look ahead to 2023.
Top